Pfizer Keeps Teva's Generic Lipitor Out Of U.K. For Now; Wins Six Month Patent Extension
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer's block against Teva's generic Lipitor in the U.K. will remain in place until a full trial later this year; pharmacies caught between the warring factions.